Similar articles

• Blood pressure, renin-angiotensin system and urinary kallikrein in a case of juxtaglomerular cell tumor.

  Mimran A, Leckie BJ, Fourcade JC, Baldet P, Navratil H, Barjon P. Mimran A, et al. Am J Med. 1978 Sep;65(3):527-36. doi: 10.1016/0002-9343(78)90780-5. Am J Med. 1978. PMID: 717419 No abstract available.
• A renin-secreting tumour sensitive to changes in central blood volume (presumably via sympathetics) but not to circulating angiotensin II.

  Gordon RD, Tunny TJ, Klemm SA, Finn WL, Hawkins PJ, Hunyor SJ, Norris JJ. Gordon RD, et al. Clin Exp Pharmacol Physiol. 1990 Mar;17(3):185-9. doi: 10.1111/j.1440-1681.1990.tb01303.x. Clin Exp Pharmacol Physiol. 1990. PMID: 2160342
• Hypertension and secondary hyperaldosteronism associated with a renin-secreting renal juxtaglomerular-cell tumour.

  Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI, Tree M, Bell PR, Davidson JK, Ruthven IS. Brown JJ, et al. Lancet. 1973 Dec 1;2(7840):1228-32. doi: 10.1016/s0140-6736(73)90972-0. Lancet. 1973. PMID: 4128560 No abstract available.
• [Juxtaglomerular cell tumor and aldosterone-secreting renal tumor].

  Kihara I. Kihara I. Nihon Rinsho. 1971 Mar;29(3):952-9. Nihon Rinsho. 1971. PMID: 4324176 Review. Japanese. No abstract available.
• [The renin-angiotensin-aldosterone system in arterial hypertension].

  Bar-Andziak E, Feltynowski T. Bar-Andziak E, et al. Kardiol Pol. 1971;14(3):309-16. Kardiol Pol. 1971. PMID: 4332382 Review. Polish. No abstract available.